Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.
Guy Bernstein

Dr. Guy Bernstein MD

President, The Center for Urologic Care

What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Member of the Healthcare Council

Council Member Biography

Guy Bernstein, MD, is the President and a practicing Urologist at the Center for Urologic Care in Bryn Mawr, Pennsylvania. Dr. Bernstein is experienced in all aspects of urology with special interest in erectile dysfunction, male infertility, incontinence, benign prostatic hypertrophy, prostatitis, and prostate cancer. He is certified in laparoscopic and laser surgery, cryosurgery and brachytherapy for prostate cancer, minimal invasive heat treatments for BPH, and sling procedures for male and female incontinence. Dr. Bernstein is the Vice-Chairman of the Main Line Hospitals Institutional Review Board, and has participated in clinical trials for GlaxoSmithKline, Ortho-McNeil, Novartis, Genomics, Sanofi-Synthelabo, Solvay, Myriad, Dendreon, and Pfizer. He is a member of the speaker's bureau for Ortho-McNeil, GlaxoSmithKline, Sanofi-Synthelabo, Lilly Icos, and Auxilium. Since 1988, Dr. Bernstein has served as an Attending Urologic Surgeon at Bryn Mawr Hospital. (This is me - Update Profile)


Employment History

1995 - 2006
Clinical Assistant Professor of Urology, Jefferson Medical College
1988 - Unspecified
President, The Center for Urologic Care

GLG NewsSM Analyses by Guy Bernstein(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

ED and cardiovascular disease are linked

August 11, 2006

Impotence could be sign of heart disease, study says | www.cnn.com

Erectile dysfunction may be the first indicator of serious cardiovasulcar disease which warrants evaluation and treatment.

Crowded Field of OAB Medications

August 11, 2006

Trospium Chloride Meets Primary and Secondary Endpoints in Phase 3 Trial | www.ptcommunity.com

Phase III trial of Sanctura XR shows efficacy in treatment of OAB with reduced side effect of dry mouth. 

Leading institutions connect with Guy Bernstein through GLG

GLG Live Meetings with Guy Bernstein(?)

Guy Bernstein has not participated in any GLG Live Meetings.

View all GLG Live Meetings in Healthcare